Gross Profit: Revenues from operations less the associated costs.
Heron Therapeutics, Inc. (HRTX) had Gross Profit of $23.35M for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
$32.81M |
|
$-4.85M |
|
$9.46M |
|
|
Gross Profit |
$23.35M |
$37.27M |
|
$-4.46M |
|
$-0.39M |
|
$-4.85M |
|
$-4.85M |
|
$-4.85M |
|
$-4.85M |
|
$-4.85M |
|
$-4.85M |
|
$-4.46M |
|
$-4.04M |
|
152.83M |
|
152.83M |
|
$-0.03 |
|
$-0.03 |
|
| Balance Sheet Financials | |
$195.19M |
|
$15.41M |
|
$25.59M |
|
$220.78M |
|
$85.54M |
|
$174.47M |
|
$175.24M |
|
$260.78M |
|
$-40.01M |
|
$-40.01M |
|
$-40.01M |
|
151.70M |
|
| Cash Flow Statement Financials | |
$-10.75M |
|
$7.30M |
|
$0.52M |
|
$28.68M |
|
$25.74M |
|
$-2.94M |
|
$10.67M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.28 |
|
-- |
|
-- |
|
1.30 |
|
-4.36 |
|
71.17% |
|
-13.59% |
|
-13.59% |
|
-- |
|
-14.78% |
|
-14.78% |
|
$-11.82M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
0.21 |
|
0.49 |
|
183.89 |
|
12.12% |
|
12.12% |
|
-2.20% |
|
-3.61% |
|
$-0.26 |
|
$-0.08 |
|
$-0.07 |
|